Compare BIO & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIO | XP |
|---|---|---|
| Founded | 1952 | 2001 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Investment Bankers/Brokers/Service |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 8.8B |
| IPO Year | N/A | 2019 |
| Metric | BIO | XP |
|---|---|---|
| Price | $314.62 | $17.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $358.50 | $22.80 |
| AVG Volume (30 Days) | 185.7K | ★ 4.6M |
| Earning Date | 02-12-2026 | 02-17-2026 |
| Dividend Yield | N/A | ★ 1.03% |
| EPS Growth | N/A | ★ 18.53 |
| EPS | N/A | ★ 1.76 |
| Revenue | $2,557,500,000.00 | ★ $3,229,174,949.00 |
| Revenue This Year | $1.62 | $17.10 |
| Revenue Next Year | $2.26 | $12.69 |
| P/E Ratio | ★ N/A | $9.87 |
| Revenue Growth | N/A | ★ 8.33 |
| 52 Week Low | $211.43 | $10.90 |
| 52 Week High | $373.69 | $20.64 |
| Indicator | BIO | XP |
|---|---|---|
| Relative Strength Index (RSI) | 50.47 | 52.95 |
| Support Level | $316.57 | $16.84 |
| Resistance Level | $328.56 | $17.56 |
| Average True Range (ATR) | 8.58 | 0.47 |
| MACD | 0.74 | 0.14 |
| Stochastic Oscillator | 52.38 | 85.27 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.